SCHEMBL352384

SCHEMBL352384

Cc1cc(=O)oc(C)c1C(=O)N(C)Cc1nsc(NC(=O)NCc2ccc(Cl)s2)n1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.37
CYP2C9 P11712 4/20 0.37
CYP2C19 P33261 2/20 0.37
KDM4E B2RXH2 4/20 0.36
CYP1A2 P05177 4/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HPGD P15428 1/20 0.36
KMT2A Q03164 6/20 0.35
MEN1 O00255 5/20 0.35
NPSR1 Q6W5P4 1/20 0.35
LMNA P02545 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
GAA P10253 3/20 0.35
CYP3A4 P08684 1/20 0.35
TSHR P16473 2/20 0.34
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
EPHX2 P34913 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19119136 0.87 KMT2A (0.33) ALDH1A1CYP2C9CYP2C19KDM4EKMT2A
SCHEMBL353171 0.87 ALDH1A1 (0.38) ALDH1A1CYP2C9CYP2C19KDM4ECYP1A2
SCHEMBL353621 0.83 ROCK2 (0.43) ALDH1A1CYP2C9CYP2C19CYP1A2L3MBTL1
SCHEMBL354039 0.82 THRB (0.43) LMNAMAPT
SCHEMBL352427 0.81 SMN1; SMN2 (0.35) ALDH1A1KDM4EL3MBTL1HPGDKMT2A
SCHEMBL353808 0.79 TRPA1 (0.34) ALDH1A1KMT2ANPSR1SMN1; SMN2TSHR
SCHEMBL353272 0.78 KMT2A (0.37) ALDH1A1KDM4EKMT2AMEN1NPSR1
SCHEMBL352889 0.77 KMT2A (0.43) ALDH1A1KDM4ECYP1A2L3MBTL1KMT2A
SCHEMBL353276 0.77 KMT2A (0.36) ALDH1A1KDM4EL3MBTL1HPGDKMT2A
SCHEMBL353277 0.77 KMT2A (0.36) ALDH1A1KDM4EL3MBTL1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148380-B2 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds CRESTONE, INC. (US) 2012-04-03 US claimed
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds CRESTONE, INC. (US) 2012-01-19 US claimed
EP-2200440-A1 ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS Crestone, Inc. (US) 2010-06-30 EP claimed
WO-2009015208-A1 ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS REPLIDYNE, INC. (US) 2009-01-29 WO claimed
US-8148380-B2 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds CRESTONE, INC. (US) 2012-04-03 US disclosed
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds CRESTONE, INC. (US) 2012-01-19 US disclosed
EP-2200440-A1 ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS Crestone, Inc. (US) 2010-06-30 EP disclosed
WO-2009015208-A1 ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS REPLIDYNE, INC. (US) 2009-01-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds NAAA, AADAC, RPSA ALDH1A1 2806/4885CYP2C9 1089/4885CYP2C19 2013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.